Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma

J Dtsch Dermatol Ges. 2018 Feb;16(2):196-198. doi: 10.1111/ddg.13411. Epub 2018 Feb 1.

Authors

Kyle T Amber¹, Manuel Valdebran¹, Yuxin Lu², Sebastien De Feraudy¹, Kenneth G Linden¹

Affiliations

¹ Department of Dermatology, University of California Irvine, Irvine, California, USA.
² Department of Pathology, University of California Irvine Medical Center, Orange, California, USA.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Oral
Administration, Topical
Aged, 80 and over
Antibodies, Monoclonal, Humanized / adverse effects*
Antibodies, Monoclonal, Humanized / therapeutic use*
Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use
Biopsy
Clobetasol / therapeutic use
Drug Therapy, Combination
Female
Humans
Leg Dermatoses / chemically induced*
Leg Dermatoses / pathology
Lymphatic Metastasis
Melanoma / drug therapy*
Melanoma / pathology
Neoplasm Metastasis / pathology
Neoplasm Staging
Pemphigoid, Bullous / chemically induced*
Pemphigoid, Bullous / drug therapy
Pemphigoid, Bullous / pathology
Prednisone / therapeutic use
Skin / drug effects
Skin / pathology
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Clobetasol
pembrolizumab
Prednisone

Grants and funding